Heart is a major organ that is classified as the hardest working muscle in the body. The heart pumps blood non-stop throughout the body thru the circulatory system. It is responsible in supplying oxygen and nutrients to body tissues while getting rid of wastes such as carbon dioxide. Heart- indeed is the powerhouse of the human body and it is only right that we should take good care of it.
One serious cardiovascular condition is heart attack and it can trigger cardiac arrest which is one of the leading causes of deaths in the world.
Heart attacks can have devastating effects that will suddenly change the way of living of any individual afflicted by this. But, as innovations are taking place with latest medical breakthroughs, prevention and proper guidelines on cardiovascular diseases are within reach through the right connections.
The partnership between Zuellig Pharma Corporation and Amgen Philippines Inc., aims to heighten the awareness on cardiovascular diseases or CVD through various initiatives and educational campaigns. This partnership targets to improve the way CVD is prevented and being properly managed.
In a recent report by pas.gov, there are more than 130,000 deaths associated with cardiovascular diseases in the Philippines alone in 2016. CVD is a complex health condition that has many risk factors as it develops. One of the most common risk is Dyslipidemia which is caused by having abnormal level of lipids in a person’s blood.
Lipids also known as fats are responsible in maintaining power to the cells wherein cholesterol is needed in the production of bodily hormones and bile acids essential for good digestion.
The human body has both good and bad cholesterol. Low Density Lipoprotein or LDL-C is recognized as bad cholesterol and having high levels of this can contribute to the development of cardiovascular diseases. Increased LDL-C in the bloodstream predisposes an individual to developing atherosclerotic plaque deposits which blocks the arteries of the heart leading to stroke or heart attack. Maintaining the levels of LDL-C in good balance will significantly lower the chances of having cardiovascular diseases.
For years, doctors usually prescribe statins as treatment in lowering LDL-C in most patients. With the onset of various health conditions not all patients treated with statins have successful results which they would need an innovative approach. Having access to latest treatments will help manage dyslipidemia effectively which result to just the right levels of lipids while improving the way of living of patients.
Good thing that Amgen Philippines Inc. and Zuellig Pharma Corporation have the heart in committing to the improvement of the lives of dyslipidemia patients and their families by providing sound information and solution in making necessary actions in preventing and managing health risks associated with CVD.